Key facts
- Arthromeda’s last known valuation is $22.8M (Jan 2020).
- It has raised $12.1M across 6 recorded rounds; the latest was Seed Round ($1.8M) in Feb 2019.
- Notable investors include Thornapple River Capital.
- Arthromeda has filed 10 Form Ds with the SEC since 2014, most recently Jul 2025 ($3.2M sold to 12 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Arthromeda
Funding rounds
6 roundsAbout Arthromeda
Developer of patient-specific medical technologies designed to improve arthroplasty surgery. The company's technologies utilize micro-sensors, wireless systems, and custom software applications and offer an intelligent platform for computer-assisted hip arthroplasty surgery and cloud-based digital templating software, which provides better clinical outcomes by improving implant fit via rapid and precise preoperative digital templating, enabling surgeons to minimize implant failure and revision rates.
- Sector
- Healthcare
- HQ
- Lowell, MA, United States
- Founded
- 2011
- Website
- arthromeda.com/
- Ownership
- Privately Held (backing)
Arthromeda doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arthromeda shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arthromeda in its N-PORT filings yet. We sweep new filings monthly.